We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.47T
| $1.51B | 5.98% |
6,493,213
-94,614
| -1% | -$21.1M |
|
2
Microsoft
MSFT
$3.76T
| $1.44B | 5.7% |
3,351,220
+41,589
| +1% | +$17.8M |
|
|
3
NVIDIA
NVDA
$5.29T
| $1.34B | 5.28% |
10,994,643
-197,248
| -2% | -$23.3M |
|
4
Eli Lilly
LLY
$1.09T
| $680M | 2.69% |
767,025
+8,926
| +1% | +$8.02M |
|
5
Meta Platforms (Facebook)
META
$1.51T
| $620M | 2.45% |
1,082,285
+56,362
| +5% | +$29M |
|
6
UnitedHealth
UNH
$373B
| $513M | 2.03% |
876,671
+8,621
| +1% | +$4.88M |
|
|
7
Broadcom
AVGO
$2.01T
| $511M | 2.02% |
2,963,813
-235,867
| -7% | -$37.8M |
|
8
Alphabet (Google) Class A
GOOGL
$4.33T
| $466M | 1.84% |
2,808,189
-63,252
| -2% | -$10.6M |
|
|
9
Alphabet (Google) Class C
GOOG
$4.31T
| $439M | 1.74% |
2,628,176
+115,716
| +5% | +$19.6M |
|
|
10
Merck
MRK
$323B
| $355M | 1.41% |
3,130,042
+967,462
| +45% | +$115M |
|
11
Mastercard
MA
$491B
| $310M | 1.22% |
627,011
+43,679
| +7% | +$20.3M |
|
12
JPMorgan Chase
JPM
$951B
| $266M | 1.05% |
1,263,820
+34,760
| +3% | +$7.32M |
|
13
Johnson & Johnson
JNJ
$627B
| $243M | 0.96% |
1,501,599
+26,672
| +2% | +$4.25M |
|
14
Thermo Fisher Scientific
TMO
$220B
| $243M | 0.96% |
392,981
+2,320
| +0.6% | +$1.37M |
|
15
AbbVie
ABBV
$434B
| $226M | 0.9% |
1,145,941
+16,817
| +1% | +$3.14M |
|
16
Berkshire Hathaway Class B
BRK.B
$1.14T
| $214M | 0.84% |
464,057
+9,389
| +2% | +$4.15M |
|
|
17
Boston Scientific
BSX
$73.4B
| $199M | 0.79% |
2,371,407
+965,080
| +69% | +$76.1M |
|
18
Abbott
ABT
$188B
| $193M | 0.76% |
1,692,554
+77,091
| +5% | +$8.46M |
|
19
Vertex Pharmaceuticals
VRTX
$134B
| $191M | 0.76% |
411,515
-4,866
| -1% | -$2.34M |
|
20
Intuit
INTU
$91.3B
| $189M | 0.75% |
303,931
+2,060
| +0.7% | +$1.31M |
|
21
Visa
V
$672B
| $158M | 0.62% |
573,024
+15,176
| +3% | +$4.1M |
|
22
Jack Henry & Associates
JKHY
$11.1B
| $152M | 0.6% |
863,800
+66,600
| +8% | +$11.3M |
|
23
Procter & Gamble
PG
$339B
| $148M | 0.59% |
855,587
+17,785
| +2% | +$3.02M |
|
|
24
Fluence Energy
FLNC
$2.34B
| $145M | 0.57% |
6,376,024
+2,047,063
| +47% | +$37M |
|
25
Service Corp International
SCI
$11.4B
| $143M | 0.57% |
1,810,148
+61,838
| +4% | +$4.7M |
|
Similar funds
SAM
VIA
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.